33307172|t|Acute neuroinflammation, sickness behavior and working memory responses to acute systemic LPS challenge following noradrenergic lesion in mice.
33307172|a|Locus coeruleus (LC)-derived noradrenaline is important in cognition and decreases with age, but the impact of prior noradrenaline deficiency on vulnerability to inflammation-induced acute cognitive dysfunction is unclear. Here we assessed whether noradrenergic depletion, in female mice, impacted upon inflammation, locomotor activity and working memory directly after acute systemic immune challenge with bacterial lipopolysaccharide (LPS), a paradigm we have previously used to capture delirium-like acute cognitive deficits. Mice received 2 doses of the LC-selective noradrenergic toxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4; 50 mg/kg i.p.) and were challenged, 2 weeks later, with LPS (100 mug/kg i.p.). DSP-4 dramatically reduced noradrenaline concentrations and tyrosine hydroxylase-positive afferents in the frontal cortex and hippocampus. This did not significantly alter numbers of Pu.1-positive microglia, Iba1-positive microglial morphology or mRNA expression of microglia-associated gene transcripts (Tyrobp, Sall1, Cd68, Sra2, Clec7a) in the hippocampus or frontal cortex and produced modest reductions in Cx3cr1 and P2ry12. LPS induced blood and brain cytokine levels, cFOS activation and locomotor responses that were highly similar in DSP-4- and vehicle-treated mice, although LPS-induced plasma TNF-alpha was significantly reduced in those treated with DSP-4. Importantly, prior noradrenergic depletion did not predispose to LPS-induced T-maze working memory deficits. The data demonstrate that significant depletion of noradrenaline in the hippocampus and frontal cortex does not prompt acutely exaggerated neuroinflammation or leave the brain vulnerable to acute, transient working memory deficits upon low dose LPS challenge. These findings have implications for our understanding of the impact of systemic inflammation on the aging and vulnerable brain during septic encephalopathy and delirium.
33307172	6	23	neuroinflammation	Disease	MESH:D000090862
33307172	90	93	LPS	Chemical	MESH:D008070
33307172	114	134	noradrenergic lesion	Disease	MESH:D009059
33307172	138	142	mice	Species	10090
33307172	173	186	noradrenaline	Chemical	MESH:D009638
33307172	261	285	noradrenaline deficiency	Disease	MESH:C535600
33307172	306	318	inflammation	Disease	MESH:D007249
33307172	333	354	cognitive dysfunction	Disease	MESH:D003072
33307172	427	431	mice	Species	10090
33307172	447	459	inflammation	Disease	MESH:D007249
33307172	561	579	lipopolysaccharide	Chemical	MESH:D008070
33307172	581	584	LPS	Chemical	MESH:D008070
33307172	633	641	delirium	Disease	MESH:D003693
33307172	653	671	cognitive deficits	Disease	MESH:D003072
33307172	673	677	Mice	Species	10090
33307172	735	779	N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine	Chemical	MESH:C012102
33307172	781	786	DSP-4	Chemical	MESH:C012102
33307172	844	847	LPS	Chemical	MESH:D008070
33307172	867	872	DSP-4	Chemical	MESH:C012102
33307172	894	907	noradrenaline	Chemical	MESH:D009638
33307172	927	947	tyrosine hydroxylase	Gene	21823
33307172	1050	1054	Pu.1	Gene	20375
33307172	1075	1079	Iba1	Gene	114737
33307172	1172	1178	Tyrobp	Gene	22177
33307172	1180	1185	Sall1	Gene	58198
33307172	1187	1191	Cd68	Gene	12514
33307172	1199	1205	Clec7a	Gene	56644
33307172	1278	1284	Cx3cr1	Gene	13051
33307172	1289	1295	P2ry12	Gene	70839
33307172	1297	1300	LPS	Chemical	MESH:D008070
33307172	1342	1346	cFOS	Gene	14281
33307172	1410	1415	DSP-4	Chemical	MESH:C012102
33307172	1437	1441	mice	Species	10090
33307172	1452	1455	LPS	Chemical	MESH:D008070
33307172	1471	1480	TNF-alpha	Gene	21926
33307172	1529	1534	DSP-4	Chemical	MESH:C012102
33307172	1601	1604	LPS	Chemical	MESH:D008070
33307172	1628	1643	memory deficits	Disease	MESH:D008569
33307172	1696	1709	noradrenaline	Chemical	MESH:D009638
33307172	1784	1801	neuroinflammation	Disease	MESH:D000090862
33307172	1860	1875	memory deficits	Disease	MESH:D008569
33307172	1890	1893	LPS	Chemical	MESH:D008070
33307172	1986	1998	inflammation	Disease	MESH:D007249
33307172	2040	2046	septic	Disease	MESH:D001170
33307172	2047	2061	encephalopathy	Disease	MESH:D001927
33307172	2066	2074	delirium	Disease	MESH:D003693
33307172	Negative_Correlation	MESH:C012102	21926
33307172	Positive_Correlation	MESH:D008070	MESH:D000090862
33307172	Negative_Correlation	MESH:C012102	13051
33307172	Positive_Correlation	MESH:D008070	MESH:D008569
33307172	Negative_Correlation	MESH:C012102	21823
33307172	Negative_Correlation	MESH:C012102	70839
33307172	Positive_Correlation	MESH:D008070	MESH:D003693
33307172	Negative_Correlation	MESH:C012102	MESH:D008070
33307172	Positive_Correlation	MESH:D008070	14281
33307172	Negative_Correlation	MESH:C012102	MESH:D009638
33307172	Positive_Correlation	MESH:D008070	MESH:D003072
33307172	Positive_Correlation	MESH:D008070	21926

